Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease

The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Infiltrative heart disease refers to accumulation of abnormal substances wi...

Full description

Saved in:
Bibliographic Details
Published inJACC. Cardiovascular imaging Vol. 5; no. 9; pp. 897 - 907
Main Authors Mongeon, François-Pierre, Jerosch-Herold, Michael, Coelho-Filho, Otávio Rizzi, Blankstein, Ron, Falk, Rodney H., Kwong, Raymond Y.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2012
Subjects
Online AccessGet full text
ISSN1936-878X
1876-7591
1876-7591
DOI10.1016/j.jcmg.2012.04.006

Cover

Abstract The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE. We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed. Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE. The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.
AbstractList Objectives The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Background Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE. Methods We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed. Results Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE. Conclusions The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.
The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.OBJECTIVESThe aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.BACKGROUNDInfiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE.We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.METHODSWe performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed.Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.RESULTSSeventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE.The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.CONCLUSIONSThe CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.
The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease. Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium. Qualitative assessment of late gadolinium enhancement (LGE) remains the most commonly used method for CMR evaluation of patients suspected with myocardial infiltration. This technique is widely available and can be performed in a reproducible and standardized manner. However, the degree of extracellular matrix expansion due to myocardial infiltration in the intercellular space has, to date, not been amenable to noninvasive quantification with LGE. We performed 3-T CMR in 38 patients (mean age 68 ± 15 years) who were referred for assessment of infiltrative heart disease and also in 9 healthy volunteers as control subjects. The T1 quantification by Look-Locker gradient-echo before and after contrast determined segmental myocardial partition coefficients. The ECF was obtained by referencing the tissue partition coefficient for gadolinium to the plasma volume fraction in blood, derived from serum hematocrit. Cine CMR and LGE imaging in matching locations were also performed. Seventeen patients (45%) had cardiac amyloidosis (CA) (biopsy-confirmed or clinically highly probable), 20 (53%) had a non-amyloid cardiomyopathy, and 1 had lysosomal storage disease. Median global ECF was substantially higher in CA patients (0.49) compared with non-amyloid cardiomyopathy patients (0.33, p < 0.0001) and volunteers (0.24, p = 0.0001). The ECF strongly correlated with visually assessed segmental LGE (r = 0.80, p < 0.0001) and LV mass index (r = 0.69, p < 0.0001), reflecting severity of myocardial infiltration. In patients with CA, ECF was highest in segments with LGE, although it remained elevated in segments without qualitative LGE. The CMR ECF quantification identified substantial expansion of the interstitial space in patients with CA compared with volunteers. Further studies using this technique for diagnosis and assessment of the severity of myocardial infiltration are warranted.
Author Falk, Rodney H.
Blankstein, Ron
Coelho-Filho, Otávio Rizzi
Jerosch-Herold, Michael
Kwong, Raymond Y.
Mongeon, François-Pierre
AuthorAffiliation Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
Noninvasive Cardiology Service, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
AuthorAffiliation_xml – name: Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
– name: Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
– name: Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
– name: Noninvasive Cardiology Service, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Author_xml – sequence: 1
  givenname: François-Pierre
  surname: Mongeon
  fullname: Mongeon, François-Pierre
  organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
– sequence: 2
  givenname: Michael
  surname: Jerosch-Herold
  fullname: Jerosch-Herold, Michael
  organization: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
– sequence: 3
  givenname: Otávio Rizzi
  surname: Coelho-Filho
  fullname: Coelho-Filho, Otávio Rizzi
  organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
– sequence: 4
  givenname: Ron
  surname: Blankstein
  fullname: Blankstein, Ron
  organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
– sequence: 5
  givenname: Rodney H.
  surname: Falk
  fullname: Falk, Rodney H.
  organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
– sequence: 6
  givenname: Raymond Y.
  surname: Kwong
  fullname: Kwong, Raymond Y.
  email: rykwong@partners.org
  organization: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22974802$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1DAUtVARfcAPsEBZskmwHSd2WCChodBKrRCPSuyuPM518ZCxp3Yy6vw9Dp0iQKIrW_Z5-J7jY3Lgg0dCnjNaMcraV6tqZdbXFaeMV1RUlLaPyBFTsi1l07GDvO_qtlRSfTskxymtMoC2Qj4hh5x3UijKj8jVp0n70Vln9OiCL4ItTm_HqA0OwzToWFzqMbrbfLjRPs2I5a5YXH4unC_OvXVDxo5ui8UZ6jgW71xCnfApeWz1kPDZfj0hV-9Pvy7OyouPH84Xby9K00gxllawrqGG2qWkVItetW3dcKWtRaM6ZlGqXlqz7A1nHa37ptGCWSEldrpnyOoT8uZOdzMt19gb9Pk5A2yiW-u4g6Ad_H3j3Xe4Dluou0Y0VGSBl3uBGG4mTCOsXZpn1x7DlIDRulNK5FAz9MWfXr9N7rPMAHUHMDGkFNGCceOvVLO1G7IWzLXBCubaYK4NqIDcSqbyf6j36g-S9sNjTnjrMIIZnM9FDj9wh2kVpuhz-MAgZQ58mX_D_BkYp7SpeZ0FXv9fAPrgHnL_Cb2axr0
CitedBy_id crossref_primary_10_1016_j_jcmg_2015_05_014
crossref_primary_10_1016_j_jcmg_2015_11_002
crossref_primary_10_1177_2047487319877708
crossref_primary_10_1186_s12872_018_0952_8
crossref_primary_10_15829_1560_4071_2023_5259
crossref_primary_10_2478_ahp_2018_0002
crossref_primary_10_1016_j_jacc_2013_08_002
crossref_primary_10_1016_j_jcmg_2013_05_005
crossref_primary_10_1136_heartjnl_2022_321115
crossref_primary_10_1016_j_rx_2015_12_007
crossref_primary_10_1002_jmri_25720
crossref_primary_10_1016_j_tcm_2017_07_004
crossref_primary_10_1161_CIRCULATIONAHA_115_016567
crossref_primary_10_1055_a_1334_8434
crossref_primary_10_3348_kjr_2017_18_1_113
crossref_primary_10_1007_s11886_024_02114_6
crossref_primary_10_1016_j_cardfail_2017_08_445
crossref_primary_10_1016_j_jcmg_2012_10_030
crossref_primary_10_1002_ehf2_12565
crossref_primary_10_1007_s10554_018_1385_2
crossref_primary_10_1148_rg_346140030
crossref_primary_10_1016_j_jcmg_2015_11_005
crossref_primary_10_1161_JAHA_113_000279
crossref_primary_10_3390_biomedicines13010079
crossref_primary_10_1007_s11864_020_00738_8
crossref_primary_10_1007_s11886_019_1097_9
crossref_primary_10_1007_s10554_018_1320_6
crossref_primary_10_3389_fcvm_2024_1359657
crossref_primary_10_2174_1381612829666221212100114
crossref_primary_10_2147_VHRM_S295376
crossref_primary_10_1161_CIRCULATIONAHA_115_019949
crossref_primary_10_1007_s00330_017_4845_5
crossref_primary_10_1161_CIRCIMAGING_113_000178
crossref_primary_10_1097_CRD_0000000000000695
crossref_primary_10_1093_eurheartj_ehu444
crossref_primary_10_1186_s12968_020_00622_2
crossref_primary_10_17996_anc_20_00130
crossref_primary_10_1371_journal_pone_0263378
crossref_primary_10_1016_j_jcmg_2012_11_013
crossref_primary_10_1093_ehjopen_oead092
crossref_primary_10_1155_2022_3094933
crossref_primary_10_1007_s12350_013_9800_5
crossref_primary_10_1161_HCI_0000000000000081
crossref_primary_10_1186_s12872_016_0311_6
crossref_primary_10_1136_openhrt_2017_000717
crossref_primary_10_1093_ehjci_jeaa310
crossref_primary_10_1007_s10741_014_9470_7
crossref_primary_10_1161_CIRCIMAGING_116_003951
crossref_primary_10_1186_1532_429X_15_92
crossref_primary_10_1161_CIRCIMAGING_113_001396
crossref_primary_10_1016_j_mric_2014_08_007
crossref_primary_10_1007_s40119_013_0017_0
crossref_primary_10_1016_j_repc_2021_04_005
crossref_primary_10_1016_j_jacc_2013_10_084
crossref_primary_10_1586_14779072_2015_1093936
crossref_primary_10_1159_000478901
crossref_primary_10_1148_radiol_2016141802
crossref_primary_10_1016_j_crad_2020_09_023
crossref_primary_10_1007_s10741_018_9718_8
crossref_primary_10_1007_s12410_017_9416_2
crossref_primary_10_1016_j_jcmg_2013_12_002
crossref_primary_10_3389_fcvm_2022_830572
crossref_primary_10_1016_j_jcmg_2019_06_023
crossref_primary_10_1161_CIRCULATIONAHA_115_018832
crossref_primary_10_1186_1532_429X_14_90
crossref_primary_10_1007_s12350_015_0149_9
crossref_primary_10_1007_s12410_017_9399_z
crossref_primary_10_1016_j_mri_2014_08_023
crossref_primary_10_1016_j_rxeng_2016_05_004
crossref_primary_10_1002_ehf2_12511
crossref_primary_10_1007_s11886_021_01564_6
crossref_primary_10_1016_j_jcmg_2012_04_007
crossref_primary_10_1016_j_echo_2019_09_022
crossref_primary_10_1016_j_hfc_2018_12_007
crossref_primary_10_1007_s10554_015_0595_0
crossref_primary_10_1016_j_jcmg_2024_05_004
crossref_primary_10_1161_CIRCIMAGING_120_010785
crossref_primary_10_1186_s12968_015_0181_6
crossref_primary_10_1016_j_jacc_2016_02_018
crossref_primary_10_1586_14779072_2014_876363
crossref_primary_10_1016_j_jcmg_2020_02_025
crossref_primary_10_1186_s12968_017_0419_6
crossref_primary_10_15212_CVIA_2016_0066
crossref_primary_10_1007_s13244_014_0366_9
crossref_primary_10_1016_j_amjcard_2012_11_022
crossref_primary_10_1016_j_jacc_2014_01_068
crossref_primary_10_1002_jmri_27459
crossref_primary_10_1007_s11936_017_0500_3
crossref_primary_10_36660_abc_20210718
crossref_primary_10_1016_j_mric_2019_04_007
crossref_primary_10_3390_jpm14040407
crossref_primary_10_57187_s_4186
crossref_primary_10_1007_s11936_016_0469_3
crossref_primary_10_3390_bioengineering10030345
crossref_primary_10_1093_ehjci_jead350
crossref_primary_10_1161_CIRCIMAGING_124_017475
crossref_primary_10_2459_JCM_0000000000001695
crossref_primary_10_1016_j_jcmg_2013_08_015
crossref_primary_10_1016_j_jcmg_2019_07_015
crossref_primary_10_1016_j_recesp_2016_04_036
crossref_primary_10_1007_s12350_015_0235_z
crossref_primary_10_1016_j_jcmg_2013_01_007
crossref_primary_10_1186_s12880_015_0099_3
crossref_primary_10_1007_s10741_016_9580_5
crossref_primary_10_3390_ph15091145
crossref_primary_10_1016_j_jcmg_2013_08_013
crossref_primary_10_1016_j_jcmg_2023_10_010
crossref_primary_10_31083_j_rcm_2021_01_134
crossref_primary_10_1161_CIRCULATIONAHA_114_009362
crossref_primary_10_1002_mrm_28675
crossref_primary_10_1007_s40119_022_00299_x
crossref_primary_10_1016_j_rec_2016_04_045
crossref_primary_10_1186_s12968_018_0478_3
Cites_doi 10.1002/mrm.20110
10.1016/0002-9149(82)90270-3
10.1016/j.jacc.2010.11.013
10.1016/j.jacc.2008.06.049
10.1016/j.jacc.2008.08.064
10.1016/j.amjcard.2004.04.026
10.1161/01.CIR.0000152819.97857.9D
10.1016/j.jacc.2009.12.040
10.1056/NEJMoa033349
10.1148/radiology.211.3.r99jn41698
10.1002/mrm.20830
10.1016/j.jacc.2009.04.094
10.2214/AJR.08.1201
10.1016/j.jacc.2007.10.049
10.1002/mrm.20236
10.1152/ajpheart.00429.2008
10.1186/1756-6649-9-5
10.1161/CIRCULATIONAHA.109.930636
10.1186/1532-429X-13-16
10.1148/radiology.218.3.r01fe18703
10.1016/j.jcmg.2009.09.023
10.1186/1532-429X-11-12
10.1186/1532-429X-10-54
10.1016/j.pcad.2009.11.007
10.1016/j.amjcard.2008.09.105
10.1161/CIRCIMAGING.108.842096
10.1080/13506120802193233
10.1016/j.jcmg.2009.08.008
ContentType Journal Article
Copyright 2012 American College of Cardiology Foundation
American College of Cardiology Foundation
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
2012 by the American College of Cardiology Foundation 2012
Copyright_xml – notice: 2012 American College of Cardiology Foundation
– notice: American College of Cardiology Foundation
– notice: Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: 2012 by the American College of Cardiology Foundation 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jcmg.2012.04.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1876-7591
EndPage 907
ExternalDocumentID PMC3954504
22974802
10_1016_j_jcmg_2012_04_006
1_s2_0_S1936878X12005323
S1936878X12005323
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institutes of Health
  grantid: R01HL091157
– fundername: National Institutes of Health
  grantid: R01HL090634-01A1
– fundername: NHLBI NIH HHS
  grantid: R01HL091157
– fundername: NHLBI NIH HHS
  grantid: R01HL090634-01A1
– fundername: NHLBI NIH HHS
  grantid: R01 HL091157
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AAEDT
AAEDW
AAIKJ
AALRI
AAOAW
AAQFI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACGFO
ACGFS
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AEUPX
AEVXI
AEXQZ
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BLXMC
CS3
DIK
E3Z
EBS
EFKBS
EJD
F5P
FDB
FEDTE
FNPLU
GBLVA
H13
HVGLF
HZ~
IXB
J1W
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SDF
SEL
SES
SSZ
W8F
Z5R
0SF
6I.
AACTN
AAFTH
ABVKL
AFCTW
AFETI
AJOXV
AMFUW
NCXOZ
RIG
T5K
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFLBG
5PM
ID FETCH-LOGICAL-c574t-f41950c0fb700a4d8663528affec891fe78d7fcbdc21903d55a41f477e9ad1e13
ISSN 1936-878X
1876-7591
IngestDate Thu Aug 21 18:19:51 EDT 2025
Fri Sep 05 11:49:40 EDT 2025
Thu Apr 03 07:09:49 EDT 2025
Tue Jul 01 00:39:11 EDT 2025
Thu Apr 24 23:00:15 EDT 2025
Sun Feb 23 10:20:25 EST 2025
Tue Aug 26 16:32:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords infiltrative cardiomyopathy
myocardial delayed enhancement
ECG
LVEF
CMR
ECF
LV
LGE
left ventricular mass
T1 mapping
amyloid
λGd
CA
myocardial extracellular fraction
left ventricular ejection fraction
λ Gd
electrocardiogram
cardiac amyloidosis
partition coefficient for gadolinium
late gadolinium enhancement
left ventricular
cardiac magnetic resonance
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
https://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c574t-f41950c0fb700a4d8663528affec891fe78d7fcbdc21903d55a41f477e9ad1e13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S1936878X12005323
PMID 22974802
PQID 1039884187
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3954504
proquest_miscellaneous_1039884187
pubmed_primary_22974802
crossref_citationtrail_10_1016_j_jcmg_2012_04_006
crossref_primary_10_1016_j_jcmg_2012_04_006
elsevier_clinicalkeyesjournals_1_s2_0_S1936878X12005323
elsevier_clinicalkey_doi_10_1016_j_jcmg_2012_04_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-09-01
PublicationDateYYYYMMDD 2012-09-01
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JACC. Cardiovascular imaging
PublicationTitleAlternate JACC Cardiovasc Imaging
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Maceira, Joshi, Prasad (bib4) 2005; 111
Iles, Pfluger, Phrommintikul (bib15) 2008; 52
Falk, Dubrey (bib25) 2010; 52
Ha, Ommen, Tajik (bib24) 2004; 94
Hosch, Kristen, Libicher (bib5) 2008; 15
Arad, Maron, Gorham (bib3) 2005; 352
Vogelsberg, Mahrholdt, Deluigi (bib9) 2008; 51
Rudolph, Abdel-Aty, Bohl (bib12) 2009; 53
Flacke, Fischer, Lorenz (bib26) 2001; 218
Ruberg, Appelbaum, Davidoff (bib7) 2009; 103
Migrino, Christenson, Szabo, Bright, Truran, Hari (bib10) 2009; 9
Austin, Tang, Rodriguez (bib6) 2009; 2
Flett, Hayward, Ashworth (bib21) 2010; 122
Messroghli, Radjenovic, Kozerke, Higgins, Sivananthan, Ridgway (bib14) 2004; 52
Thornhill, Prato, Wisenberg, White, Nowell, Sauer (bib17) 2006; 55
Arheden, Saeed, Higgins (bib18) 1999; 211
Schelbert, Testa, Meier (bib27) 2011; 13
De Cobelli, Esposito, Belloni (bib2) 2009; 192
Karamitsos, Francis, Myerson, Selvanayagam, Neubauer (bib28) 2009; 54
Jerosch-Herold, Sheridan, Kushner (bib19) 2008; 295
Seward, Casaclang-Verzosa (bib1) 2010; 55
Syed, Glockner, Feng (bib8) 2010; 3
Broberg, Chugh, Conklin, Sahn, Jerosch-Herold (bib20) 2010; 3
Piotrowska-Kownacka, Kownacki, Kuch (bib11) 2009; 11
Carroll, Gaasch, McAdam (bib23) 1982; 49
Maceira, Prasad, Hawkins, Roughton, Pennell (bib22) 2008; 10
Thornhill, Prato, Wisenberg, Moran, Sykes (bib16) 2004; 52
Mewton, Liu, Croisille, Bluemke, Lima (bib13) 2011; 57
Falk (10.1016/j.jcmg.2012.04.006_bib25) 2010; 52
Ruberg (10.1016/j.jcmg.2012.04.006_bib7) 2009; 103
Seward (10.1016/j.jcmg.2012.04.006_bib1) 2010; 55
Mewton (10.1016/j.jcmg.2012.04.006_bib13) 2011; 57
Migrino (10.1016/j.jcmg.2012.04.006_bib10) 2009; 9
Thornhill (10.1016/j.jcmg.2012.04.006_bib17) 2006; 55
Karamitsos (10.1016/j.jcmg.2012.04.006_bib28) 2009; 54
Maceira (10.1016/j.jcmg.2012.04.006_bib4) 2005; 111
Vogelsberg (10.1016/j.jcmg.2012.04.006_bib9) 2008; 51
Messroghli (10.1016/j.jcmg.2012.04.006_bib14) 2004; 52
Ha (10.1016/j.jcmg.2012.04.006_bib24) 2004; 94
Flacke (10.1016/j.jcmg.2012.04.006_bib26) 2001; 218
Arad (10.1016/j.jcmg.2012.04.006_bib3) 2005; 352
Austin (10.1016/j.jcmg.2012.04.006_bib6) 2009; 2
Syed (10.1016/j.jcmg.2012.04.006_bib8) 2010; 3
Piotrowska-Kownacka (10.1016/j.jcmg.2012.04.006_bib11) 2009; 11
Broberg (10.1016/j.jcmg.2012.04.006_bib20) 2010; 3
Schelbert (10.1016/j.jcmg.2012.04.006_bib27) 2011; 13
Jerosch-Herold (10.1016/j.jcmg.2012.04.006_bib19) 2008; 295
Flett (10.1016/j.jcmg.2012.04.006_bib21) 2010; 122
Thornhill (10.1016/j.jcmg.2012.04.006_bib16) 2004; 52
Carroll (10.1016/j.jcmg.2012.04.006_bib23) 1982; 49
Rudolph (10.1016/j.jcmg.2012.04.006_bib12) 2009; 53
De Cobelli (10.1016/j.jcmg.2012.04.006_bib2) 2009; 192
Iles (10.1016/j.jcmg.2012.04.006_bib15) 2008; 52
Arheden (10.1016/j.jcmg.2012.04.006_bib18) 1999; 211
Maceira (10.1016/j.jcmg.2012.04.006_bib22) 2008; 10
Hosch (10.1016/j.jcmg.2012.04.006_bib5) 2008; 15
22974803 - JACC Cardiovasc Imaging. 2012 Sep;5(9):908-10. doi: 10.1016/j.jcmg.2012.04.007
References_xml – volume: 352
  start-page: 362
  year: 2005
  end-page: 372
  ident: bib3
  article-title: Glycogen storage diseases presenting as hypertrophic cardiomyopathy
  publication-title: N Engl J Med
– volume: 2
  start-page: 1369
  year: 2009
  end-page: 1377
  ident: bib6
  article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis
  publication-title: J Am Coll Cardiol Img
– volume: 52
  start-page: 141
  year: 2004
  end-page: 146
  ident: bib14
  article-title: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart
  publication-title: Magn Reson Med
– volume: 52
  start-page: 1069
  year: 2004
  end-page: 1079
  ident: bib16
  article-title: Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction
  publication-title: Magn Reson Med
– volume: 54
  start-page: 1407
  year: 2009
  end-page: 1424
  ident: bib28
  article-title: The role of cardiovascular magnetic resonance imaging in heart failure
  publication-title: J Am Coll Cardiol
– volume: 9
  start-page: 5
  year: 2009
  ident: bib10
  article-title: Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up
  publication-title: BMC Med Phys
– volume: 10
  start-page: 54
  year: 2008
  ident: bib22
  article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis
  publication-title: J Cardiovasc Magn Reson
– volume: 53
  start-page: 284
  year: 2009
  end-page: 291
  ident: bib12
  article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling
  publication-title: J Am Coll Cardiol
– volume: 51
  start-page: 1022
  year: 2008
  end-page: 1030
  ident: bib9
  article-title: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy
  publication-title: J Am Coll Cardiol
– volume: 122
  start-page: 138
  year: 2010
  end-page: 144
  ident: bib21
  article-title: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans
  publication-title: Circulation
– volume: 3
  start-page: 727
  year: 2010
  end-page: 734
  ident: bib20
  article-title: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease
  publication-title: Circ Cardiovasc Imaging
– volume: 94
  start-page: 316
  year: 2004
  end-page: 319
  ident: bib24
  article-title: Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography
  publication-title: Am J Cardiol
– volume: 111
  start-page: 186
  year: 2005
  end-page: 193
  ident: bib4
  article-title: Cardiovascular magnetic resonance in cardiac amyloidosis
  publication-title: Circulation
– volume: 57
  start-page: 891
  year: 2011
  end-page: 903
  ident: bib13
  article-title: Assessment of myocardial fibrosis with cardiovascular magnetic resonance
  publication-title: J Am Coll Cardiol
– volume: 3
  start-page: 155
  year: 2010
  end-page: 164
  ident: bib8
  article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
  publication-title: J Am Coll Cardiol Img
– volume: 11
  start-page: 12
  year: 2009
  ident: bib11
  article-title: Cardiovascular magnetic resonance findings in a case of Danon disease
  publication-title: J Cardiovasc Magn Reson
– volume: 15
  start-page: 196
  year: 2008
  end-page: 204
  ident: bib5
  article-title: Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings
  publication-title: Amyloid
– volume: 52
  start-page: 1574
  year: 2008
  end-page: 1580
  ident: bib15
  article-title: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping
  publication-title: J Am Coll Cardiol
– volume: 49
  start-page: 9
  year: 1982
  end-page: 13
  ident: bib23
  article-title: Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation
  publication-title: Am J Cardiol
– volume: 192
  start-page: W97
  year: 2009
  end-page: W102
  ident: bib2
  article-title: Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy
  publication-title: AJR Am J Roentgenol
– volume: 103
  start-page: 544
  year: 2009
  end-page: 549
  ident: bib7
  article-title: Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis
  publication-title: Am J Cardiol
– volume: 13
  start-page: 16
  year: 2011
  ident: bib27
  article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus
  publication-title: J Cardiovasc Magn Reson
– volume: 295
  start-page: H1234
  year: 2008
  end-page: H1242
  ident: bib19
  article-title: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 218
  start-page: 703
  year: 2001
  end-page: 710
  ident: bib26
  article-title: Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction
  publication-title: Radiology
– volume: 55
  start-page: 1769
  year: 2010
  end-page: 1779
  ident: bib1
  article-title: Infiltrative cardiovascular diseases: cardiomyopathies that look alike
  publication-title: J Am Coll Cardiol
– volume: 211
  start-page: 698
  year: 1999
  end-page: 708
  ident: bib18
  article-title: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats
  publication-title: Radiology
– volume: 55
  start-page: 780
  year: 2006
  end-page: 789
  ident: bib17
  article-title: Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar
  publication-title: Magn Reson Med
– volume: 52
  start-page: 347
  year: 2010
  end-page: 361
  ident: bib25
  article-title: Amyloid heart disease
  publication-title: Prog Cardiovasc Dis
– volume: 52
  start-page: 141
  year: 2004
  ident: 10.1016/j.jcmg.2012.04.006_bib14
  article-title: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.20110
– volume: 49
  start-page: 9
  year: 1982
  ident: 10.1016/j.jcmg.2012.04.006_bib23
  article-title: Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(82)90270-3
– volume: 57
  start-page: 891
  year: 2011
  ident: 10.1016/j.jcmg.2012.04.006_bib13
  article-title: Assessment of myocardial fibrosis with cardiovascular magnetic resonance
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.11.013
– volume: 52
  start-page: 1574
  year: 2008
  ident: 10.1016/j.jcmg.2012.04.006_bib15
  article-title: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.06.049
– volume: 53
  start-page: 284
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib12
  article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.08.064
– volume: 94
  start-page: 316
  year: 2004
  ident: 10.1016/j.jcmg.2012.04.006_bib24
  article-title: Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.04.026
– volume: 111
  start-page: 186
  year: 2005
  ident: 10.1016/j.jcmg.2012.04.006_bib4
  article-title: Cardiovascular magnetic resonance in cardiac amyloidosis
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000152819.97857.9D
– volume: 55
  start-page: 1769
  year: 2010
  ident: 10.1016/j.jcmg.2012.04.006_bib1
  article-title: Infiltrative cardiovascular diseases: cardiomyopathies that look alike
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.12.040
– volume: 352
  start-page: 362
  year: 2005
  ident: 10.1016/j.jcmg.2012.04.006_bib3
  article-title: Glycogen storage diseases presenting as hypertrophic cardiomyopathy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa033349
– volume: 211
  start-page: 698
  year: 1999
  ident: 10.1016/j.jcmg.2012.04.006_bib18
  article-title: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats
  publication-title: Radiology
  doi: 10.1148/radiology.211.3.r99jn41698
– volume: 55
  start-page: 780
  year: 2006
  ident: 10.1016/j.jcmg.2012.04.006_bib17
  article-title: Feasibility of the single-bolus strategy for measuring the partition coefficient of Gd-DTPA in patients with myocardial infarction: independence of image delay time and maturity of scar
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.20830
– volume: 54
  start-page: 1407
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib28
  article-title: The role of cardiovascular magnetic resonance imaging in heart failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.04.094
– volume: 192
  start-page: W97
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib2
  article-title: Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.08.1201
– volume: 51
  start-page: 1022
  year: 2008
  ident: 10.1016/j.jcmg.2012.04.006_bib9
  article-title: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.10.049
– volume: 52
  start-page: 1069
  year: 2004
  ident: 10.1016/j.jcmg.2012.04.006_bib16
  article-title: Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.20236
– volume: 295
  start-page: H1234
  year: 2008
  ident: 10.1016/j.jcmg.2012.04.006_bib19
  article-title: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00429.2008
– volume: 9
  start-page: 5
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib10
  article-title: Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up
  publication-title: BMC Med Phys
  doi: 10.1186/1756-6649-9-5
– volume: 122
  start-page: 138
  year: 2010
  ident: 10.1016/j.jcmg.2012.04.006_bib21
  article-title: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.930636
– volume: 13
  start-page: 16
  year: 2011
  ident: 10.1016/j.jcmg.2012.04.006_bib27
  article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-13-16
– volume: 218
  start-page: 703
  year: 2001
  ident: 10.1016/j.jcmg.2012.04.006_bib26
  article-title: Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction
  publication-title: Radiology
  doi: 10.1148/radiology.218.3.r01fe18703
– volume: 3
  start-page: 155
  year: 2010
  ident: 10.1016/j.jcmg.2012.04.006_bib8
  article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2009.09.023
– volume: 11
  start-page: 12
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib11
  article-title: Cardiovascular magnetic resonance findings in a case of Danon disease
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-11-12
– volume: 10
  start-page: 54
  year: 2008
  ident: 10.1016/j.jcmg.2012.04.006_bib22
  article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-10-54
– volume: 52
  start-page: 347
  year: 2010
  ident: 10.1016/j.jcmg.2012.04.006_bib25
  article-title: Amyloid heart disease
  publication-title: Prog Cardiovasc Dis
  doi: 10.1016/j.pcad.2009.11.007
– volume: 103
  start-page: 544
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib7
  article-title: Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2008.09.105
– volume: 3
  start-page: 727
  year: 2010
  ident: 10.1016/j.jcmg.2012.04.006_bib20
  article-title: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease
  publication-title: Circ Cardiovasc Imaging
  doi: 10.1161/CIRCIMAGING.108.842096
– volume: 15
  start-page: 196
  year: 2008
  ident: 10.1016/j.jcmg.2012.04.006_bib5
  article-title: Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings
  publication-title: Amyloid
  doi: 10.1080/13506120802193233
– volume: 2
  start-page: 1369
  year: 2009
  ident: 10.1016/j.jcmg.2012.04.006_bib6
  article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis
  publication-title: J Am Coll Cardiol Img
  doi: 10.1016/j.jcmg.2009.08.008
– reference: 22974803 - JACC Cardiovasc Imaging. 2012 Sep;5(9):908-10. doi: 10.1016/j.jcmg.2012.04.007
SSID ssj0060647
Score 2.3790004
Snippet The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR)...
Objectives The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 897
SubjectTerms Aged
Aged, 80 and over
amyloid
Amyloidosis - pathology
Biopsy
Cardiomyopathies - pathology
Cardiovascular
Chi-Square Distribution
Contrast Media
Cross-Sectional Studies
Extracellular Matrix - pathology
Gadolinium DTPA
Humans
infiltrative cardiomyopathy
left ventricular mass
Linear Models
Lysosomal Storage Diseases - pathology
Magnetic Resonance Imaging, Cine
Middle Aged
myocardial delayed enhancement
Myocardium - pathology
Predictive Value of Tests
Retrospective Studies
Severity of Illness Index
T1 mapping
Title Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1936878X12005323
https://www.clinicalkey.es/playcontent/1-s2.0-S1936878X12005323
https://www.ncbi.nlm.nih.gov/pubmed/22974802
https://www.proquest.com/docview/1039884187
https://pubmed.ncbi.nlm.nih.gov/PMC3954504
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLaiTpr2Mu2-7CYm7a0iMmBi81hFrbJK2SVrpL4hYnBDlsLUkKnLw_7M_ujOscElaVqteyER2A5wvvgcDp-_Q8iHRE1DGijqKhVSl_lSuZHioUsz6SMNAyJuzfL91B9O2PFpeNrp_GmxllbVtCfXO9eV_I9VYR_YFVfJ3sGydlDYAd_BvrAFC8P2n2z8dZUYro-N-w4vq4sEk_GaXTpC_f1LlDMGh4QtINYcjMaY4_hYqHxR1bLfQ4B7hUKc9l1NE64eDAY9JIVscFbPdWUja6qyOMtKGwXrN--8zJfuF_C4V9Ta4wx1M2fuED5NMrrN2NcLRbLFrHSPctji4c-VHsr7mZf743y9zm3mYJEU35dNlc5xjas6c4EUkKjJXJjJNkIxZK5LC9vZOGyBLmrNrMLQeGsnHZlSudfmf5OKmPfm8vwMeXu-1rGlO8S2t5ygpSY2rLd5jGPEOEZMWaxl3e_5nGsuQO-35RH1cbWuoS6Yi6lXZhkS4fZ53BT9XH-62SbptqKek0fkYf244hwY7D0mnax4Qu6PakLGUzLZhKBTKmcDgo6BoGMh6Ex_OQBBJy-cNgQdDUGnhuAzMjk6PBkM3bpShytDzipXMawmLKmackoTlgqMY32RICVJRJ7KuEi5ktNUgoOkQRqGCfMU4zyLktTLvOA52SvKIntJHD8SMFASBBKdC0sS6adCyH6UCpbKNOgSr7mDsaxl7LGayiK-2XJdsm_7_DAiLre2DhrDxM3yZHCoMWDs1l58V69sWc8Xy9iLl9A4_oZIQaB4mNANfLii9431Y5jb0UBJkZUr6EGDSAjmCd4lLwwa7Pn7fsSZoD787gZObAPUjd88UuQzrR8fRPDYRNmrO92V1-TB1X_4DdmrLlbZW4jHq-k7_X_4C6SQ4gU
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+Extracellular+Matrix+Expansion+by+CMR+in+Infiltrative+Heart+Disease&rft.jtitle=JACC.+Cardiovascular+imaging&rft.au=Mongeon%2C+Fran%C3%A7ois-Pierre&rft.au=Jerosch-Herold%2C+Michael&rft.au=Coelho-Filho%2C+Ot%C3%A1vio+Rizzi&rft.au=Blankstein%2C+Ron&rft.date=2012-09-01&rft.issn=1936-878X&rft.volume=5&rft.issue=9&rft.spage=897&rft.epage=907&rft_id=info:doi/10.1016%2Fj.jcmg.2012.04.006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jcmg_2012_04_006
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F1936878X%2FS1936878X11X00219%2Fcov150h.gif